Lysosomal Cholesterol‑Sensing Drives Rubicon‑Mediated Autophagy Suppression in Aging
Hypothesis
Age‑dependent accumulation of free cholesterol in lysosomes activates a sensing pathway that up‑regulates Rubicon, thereby actively suppressing autophagy as a protective response to membrane stress.
Mechanistic Model
- Lysosomal cholesterol overload – With age, impaired NPC1‑mediated cholesterol export leads to lumenal free cholesterol buildup [1].
- Cholesterol‑sensing effector – Oxysterol‑binding protein‑related protein 1L (ORP1L) detects excess cholesterol and recruits the Rubicon‑VPS34 complex to the lysosomal membrane [2].
- Rubicon activation – Membrane‑anchored Rubicon sterically hinders the VPS34‑BECN1 interaction, blocking PI3P production and autophagosome nucleation [3].
- Feedback loop – Reduced autophagy diminishes cholesterol efflux via autophagolysosomal degradation of NPC1, reinforcing lysosomal cholesterol retention.
This model positions Rubicon not merely as a passive inhibitor but as a sensor‑effector that couples lipid homeostasis to autophagic flux.
Testable Predictions
- Prediction 1: Pharmacological reduction of lysosomal free cholesterol (using cyclodextrin or NPC1 activators) will decrease Rubicon protein levels and restore autophagy flux in aged tissues, even when mTORC1 remains active.
- Prediction 2: Genetic ablation of ORP1L in aged mice will attenuate Rubicon lysosomal recruitment, increase LC3‑II conversion, and ameliorate age‑related phenotypes such as renal fibrosis or α‑synuclein accumulation.
- Prediction 3: Exogenous addition of oxidized cholesterol metabolites (e.g., 7‑ketocholesterol) to young cultured cells will recapitulate Rubicon‑dependent autophagy suppression, mimicking the aged state.
Experimental Approach
In vivo
-
Treat aged (24‑month) C57BL/6 mice with hydroxypropyl‑β‑cyclodextrin (HPβCD) for 4 weeks. Measure lysosomal cholesterol filipin staining, Rubicon immunoblot of lysosomal fractions, LC3‑II/p62 ratios by western blot, and functional readouts (glomerular histology, rotarod performance). Include mTORC1 activity read‑outs (p‑S6K) to confirm independence from nutrient signaling.
-
Generate ORP1L‑floxed mice crossed with Rosa26‑CreERT2 for inducible knockout in adulthood. Administer tamoxifen at 18 months, then assess autophagy markers and age‑related pathology after 6 months.
In vitro
- Culture primary hepatocytes from young mice; load with methyl‑β‑cyclodextrin‑cholesterol complexes to raise lysosomal free cholesterol. Quantify Rubicon‑Lysosome proximity via PLA (proximity ligation assay) and autophagosome formation using mCherry‑GFP‑LC3 reporter.
- Add 7‑ketocholesterol (5 µM) to young fibroblasts and monitor Rubicon recruitment and PI3P production (GFP‑2xFYVE reporter) over time.
Controls and Falsification
- If cholesterol reduction fails to lower Rubicon or rescue autophagy despite confirmed lysosomal depletion, the hypothesis is falsified.
- If ORP1L loss does not affect Rubicon localization but still alters autophagy via another pathway, the mechanism requires revision.
By linking a specific lipid‑sensing node to the established Rubicon checkpoint, this hypothesis extends the active‑suppression framework and offers a concrete, intervenable axis for restoring autophagic competence in aging.